| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.05 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |